Neuroendocrine mechanism of anovulation in users of contraceptive subdermal implant of nomegestrol acetate (Uniplant)

Fertility and Sterility

Volumn 67, Issue 2, 1997, Pages 250-255

  Barnhart, Kurt ^a,b   Sir Pettermann, Teresa ^a,b   Devoto, Luigi ^a,b,c,d   Robinovic, Jorge ^a,b   Pommer, Ricardo ^a,b   Coutinho, Elsimar ^a,b  

^a UNIVERSITY OF CHILE   (Chile)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CHILE   (Chile)

Author keywords

LH pulse hypothalamic pituitary function; Nomegestrol acetate subdermal implants

Indexed keywords

NOMEGESTROL ACETATE;

ADULT; ANOVULATION; ARTICLE; CONTRACEPTIVE DEVICE; CORPUS LUTEUM FUNCTION; DRUG EFFECT; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMPLANT; INTRADERMAL DRUG ADMINISTRATION; MENSTRUAL CYCLE; NEUROENDOCRINE SYSTEM; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0031016358     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(97)81906-1     Document Type: Article

References (23)

1. Coutinho EM. One year contraception with a single implant containing Nomegestrol acetate (Uniplant). Contraception 1993;47:94-105.
2. Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L. Ovarian endocrine function through five years of continuous treatment with Norplant subdermal contraceptive implants. Contraception 1990;41:169-77.
3. Brache V, Faundes A. Anovulation, inadequate luteal phase and poor sperm penetration in cervical mucus during prolonged use of Norplant implants. Contraception 1985;31:261.
4. Croxatto HB, Diaz S. Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro. Contraception 1987;36:193.
5. Shaaban MM, Segal S, Salem HT, Ghaneimah SA, Khalifa E-AM, Ahmed A-G. Sonographic assessment of ovarian and endometrial changes during long-term Norplant use and their correlation with hormonal levels. Fertil Steril 1993;59:998-1002.
6. Ladipo O, Coutinho EM. Contraceptive implants. Curr Opin Obstet Gynecol 1994;6:564-9.
7. Devoto I, Pommer R, Barnhart K, Alba F, Sir T, Robinovich J, et al. Ovarian function in subjects using Uniplant. Contracept Fertil Sex (Paris) 1995;(Suppl N1-N9)23;S-32.
8. Filicori M, Santoro N, Merriam G, Crowley W. Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J Clin Endocrinol Metab 1986;62:1136.
9. Veldhuis J, Beitins I, Johnson M, Serabian M, Dufau L. Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to the stage of the menstrual cycle. J Clin Endocrinol Metab 1984;58:1050.
10. Bennet A, Lacaze C, Berrada C, Barbe V, Louvet J. Correlations between mean LH levels and LH pulse characteristics: differences between normal and anovulatory women. Clin Endocrinol (Oxf) 1991;35:431-7.
11. Schweiger U, Reinhard T, Broocks A, Karl-Martin P. Gonadotropin secretion in the second half of the menstrual cycle: a comparison of women with normal cycles, luteal phase defects and disrupted follicular development Clin Endocrinol (Oxf) 1990;32:25-32.
12. Vandenberg G, DeVane G, Yen SSC. Effects of exogenous estrogen and progestin on pituitary responsiveness to synthetic luteinizing hormone-releasing factor. J Clin Invest 1974;53:1750.
13. Soules M, Steiner R, Clifton D, Cohen N, Aksel S, Bremner W. Progesterone modulation of pulsatile luteinizing hormone secretion in normal women. J Clin Endocrinol Metab 1984;58:378.
14. Poindexter A, Dilby G, Brody S, Snabes M. The effects of a long-acting progestin on the hypothalamic-pituitary-ovarian axis in women with normal menstrual cycles. Contraception 1993;48:37-45.
15. Alvarez-Sanchez F, Brache V, Faundes A, Tejada AS. Abnormal endocrine profile among women with confirmed presumed ovulation during long-term Norplant use. Contraception 1986;33:111-9.
16. Cook D, Parfet J, Smith C, Moss G, Youngquist R, Garverick H. Secretory patterns of LH and FSH during development and hypothalamic and hypophysial characteristics following development of steroid-induced ovarian follicular cysts in dairy cattle. J Reprod Fert 1991;91:19-28.
17. Coutinho E, De Souza JA, Athayde C, Barbosa I, Alverez F, Brache V, et al. Multicenter clinical trail on the efficacy and acceptability of a single contraceptive implant of nomegestrol acetate, Uniplant. Contraception 1996;53:121-5.
18. Sir-Petterman T, Recabarren S, Bitt A, Jager W, Zimmermann V, Wila L. A simple device for serial blood collection in human subjects and animals. Exp Clin Endocrinol Diabetes 1995;103:398-401.
19. Sir-Petterman T, Devoto L. Effect of clomiphene citrate on pulsatile luteinizing hormone profile in normal women and polycystic ovary syndrome. Horm Metab Res 1989;21:3703-6.
20. Devoto L, Vega M, Navarro V, Sir T, Alba F, Castro O. Regulation of steroid hormone synthesis by human corpora lutea: failure of follicle stimulating hormone to support luteal steroidogenesis in vivo and in vitro. Fertil Steril 1989;50:628-33.
21. Veldhuis JD, Royel AD, Johnson ML. Minimizing false-positive errors in hormonal pulse detection. Am J Physiol 1985;248:E475-81.
22. Couzinet B, Brailly S, Bouchard P, Schaison G. Progesterone stimulates luteinizing hormone secretion by acting directly on the pituitary. J Clin Endocrinol Metab 1992;74:374-8.
23. Brazin B, Thevenot R, Bursaux C, Paris J. Effect of nomegestrol acetate, a new 19-nor-progesterone derivative, on pituitary-ovarian function in women. Br J Obstet Gynaecol 1987;94:1199-204.